哈哈爱呀
Lv11
70 积分
2023-10-09 加入
-
Juxtaposing the efficacies between iron-based and non-calcium phosphate binders for improving mineral and bone disorder parameters in dialysisdependent chronic kidney disease patients: A meta-analysis of randomized controlled trials
5个月前
已关闭
-
EFFICACY AND INFLUENCE ON THE KEY INDICATORS OF MINERAL-BONE DISORDERS OF THE SUCROFERRIC OXYHYDROXIDE AND SEVELAMER CARBONATE IN HEMODIALYSIS PATIENTS
6个月前
已关闭
-
Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open-label, multicentre, 12-week phase III study
7个月前
已完结
-
CHANGE IN SERUM PHOSPHORUS AND PILL BURDEN AMONG HEMODIALYSIS PATIENTS SWITCHING FROM PHOSPHATE BINDER (PB) DUAL THERAPY TO MONOTHERAPY WITH SUCROFERRIC OXYHYDROXIDE (SO)
7个月前
已关闭
-
SUCROFERRIC OXYHYDROXIDE VERSUS CALCIUM CARBONATE IN THE TREATMENT BONE METABOLISM IN PATIENTS WITH CKD3-5 EVALUATED BY 18F-NA FLUORIDE PET/CT AND BIOMARKERS: A RANDOMIZED CROSSOVER STUDY
7个月前
已关闭
-
Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study
7个月前
已完结
-
Triptolide attenuates oxidative stress, NF-kappaB activation and multiple cytokine gene expression in murine peritoneal macrophage
8个月前
已完结
-
Cardiorenal syndrome type 4: From chronic kidney disease to cardiovascular impairment
9个月前
已完结
-
Heart Failure : Pathophysiology, Diagnosis, Medical Treatment Guidelines, and Nursing Management
10个月前
已完结
-
Heart Failure : Pathophysiology, Diagnosis, Medical Treatment Guidelines, and Nursing Management
10个月前
已关闭